ロード中...
Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study
PURPOSE: Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, approved for the local treatment of unresectable metastatic melanoma. Since data on the efficacy and safety of geriat...
保存先:
| 出版年: | Cancer Manag Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8289688/ https://ncbi.nlm.nih.gov/pubmed/34290528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S286917 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|